-
BeiGene PD-1 is priced 20 times higher in the United States than in China, and innovative drugs have to go overseas to make money
BeiGene recently announced that Tevimbra, a monoclonal antibody, has been launched for sale in the United States for the treatment of unresectable or metastatic esophageal squamous cell carcinoma (ES ...